Sign inJoin waitlistJoin the waitlist

RP

Richard Pinkerton

Credentials: ·

History

Hematology and Medical Oncology
Internal Medicine

Research

Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer
Clinical Colorectal Cancer · 2012 · 13 citations
A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancer
Clinical Colorectal Cancer · 2011 · 4 citations
A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancer
American Journal of Clinical Oncology · 2005 · 4 citations

RR
Ramesh Ramanathan
3 papers
BL
Barry Lembersky
2 papers
TC
Theodore Crandall
2 papers
Benedito Carneiro
1 paper
DF
David Friedland
1 paper
EB
Edward Balaban
1 paper
Herbert Zeh
1 paper
KM
Khalid Matin
1 paper
KR
Kiran Rajasenan
1 paper
ME
Martin Earle
1 paper
MF
Marwan Fakih
1 paper
MW
Michael Wong
1 paper